Find uplifting stories about heroes, innovations, and solutions
5245 results for "neglected diseases"
AI company Anthropic is launching a drug discovery program focused on diseases that big pharmaceutical companies typically ignore. The effort pairs hands-on research with new AI tools designed to help drugmakers accelerate treatment development.
After eliminating trachoma and other neglected tropical diseases, Malawi is leading African nations to make disease prevention a human rights issue at the UN. Twenty-five African countries have now eliminated at least one neglected tropical disease, proving progress is possible.
Anthropic just launched Claude Science, an AI platform that helps scientists discover new drugs faster and cheaper. The company is also using it to develop treatments for rare diseases that big pharma often ignores.
Malawi is making remarkable progress in eliminating neglected tropical diseases, treating over 3.2 million people in 2025 with strong results. The country achieved 89% coverage for one disease and is seeing cases decline across multiple illnesses that have trapped communities in poverty for generations.
A groundbreaking treatment for Huntington's disease just cleared a major hurdle, bringing hope to 240,000 Americans affected by this devastating condition. The experimental therapy could become the first disease-modifying treatment for a disorder that has had none.
A groundbreaking treatment for myotonic dystrophy type 1 reduced toxic proteins by 40% and improved muscle function in patients who've never had disease-modifying options. The New England Journal of Medicine just published results that could lead to the first approved therapy for this progressive, often fatal disease.
Researchers discovered how to disguise healthy mitochondria so they can slip into diseased cells undetected, extending the lives of mice with a fatal genetic disorder. The breakthrough could one day help children born with rare mitochondrial diseases.
A new treatment for a rare kidney disease just passed a major test, bringing hope to 330,000 patients in the U.S. and Europe. Vertex's drug successfully reduced a key disease marker by half in late-stage trials.
University of Queensland researchers have developed a breakthrough drug that could transform Motor Neurone Disease from a terminal diagnosis into a manageable chronic condition within five years. The discovery unlocks a previously untargetable immune receptor that plays a key role in neurodegenerative diseases.
Pearl Jam's Eddie Vedder and Canadian director Matt Finlin created a documentary following the race to cure epidermolysis bullosa, a devastating skin disease affecting children worldwide. The Netflix film captures breakthrough research that could unlock treatments for thousands of rare diseases.
For the first time, a gene therapy has shown dramatic results in slowing Huntington's disease, offering hope to 8,000 UK families who've had no treatment options until now. Patients receiving the higher dose experienced 75% less disease progression over three years.
Four leading European research institutes have joined forces to speed up treatments for Alzheimer's, Parkinson's, and other brain diseases affecting millions. The CURE-ND Alliance brings together over 2,500 scientists working to transform how we understand and treat neurodegenerative diseases.
A Nashville family transformed their annual Kentucky Derby party into a powerful fundraiser after their daughter was diagnosed with an incurable nerve disease. Last year alone, they raised $75,000 for research into Charcot-Marie-Tooth disease.
Jeff Carroll learned he carried the gene for deadly Huntington's disease. Instead of giving up, he became a neuroscientist dedicated to finding a cure for the condition killing him.
After initially calling it a failed product, the FDA reversed course to allow accelerated approval of a groundbreaking gene therapy that could slow Huntington's disease. The decision brings hope to 40,000 Americans living with the fatal disorder that currently has no cure.
The FDA has accepted a groundbreaking treatment for Alexander disease for priority review, offering hope to families battling a rare neurological condition that has no approved therapies. If approved by September, zilganersen would become the first medicine ever available for this devastating illness.
The FDA reversed course on a groundbreaking gene therapy for Huntington's disease, bringing new hope to thousands of families. The treatment from biotech company UniQure can now move forward toward U.S. approval.
Deaths from coronary artery disease have dropped more than 50% in the United States over three decades, thanks to better control of key risk factors like smoking and air pollution. Even better news: nearly 90% of remaining deaths could still be prevented.
A promising treatment for microvillus inclusion disease, a deadly childhood condition, has entered breakthrough therapy talks with the FDA. The oral medication has already shown it can reduce life-sustaining interventions in young patients.
NYU is solving diseases faster by throwing out the old playbook: instead of keeping scientists in separate buildings, they're mixing engineers, doctors, and AI experts into teams focused on beating specific diseases. Early wins include a startup detecting airborne pathogens and "inverse vaccines" that could cure celiac disease and allergies.
Showing 20 of 5245